| 000 | 00846 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250517150542.0 | ||
| 264 | 0 | _c20180427 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a2468-1253 | ||
| 024 | 7 |
_a10.1016/S2468-1253(16)30220-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStelma, Femke | |
| 245 | 0 | 0 |
_aPeginterferon add-on: an added benefit? _h[electronic resource] |
| 260 |
_bThe lancet. Gastroenterology & hepatology _c03 2017 |
||
| 300 |
_a147-148 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon-alpha |
| 650 | 0 | 4 | _aRibavirin |
| 700 | 1 | _aReesink, Hendrik W | |
| 773 | 0 |
_tThe lancet. Gastroenterology & hepatology _gvol. 2 _gno. 3 _gp. 147-148 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2468-1253(16)30220-5 _zAvailable from publisher's website |
| 999 |
_c27075758 _d27075758 |
||